The performance of the Lung Imaging Fluorescence Endoscope (LIFE) system was compared with conventional bronchoscopy in 158 patients: 68 patients with invasive cancer, 42 patients with abnormal sputum cytology findings (12 early cancer and 26 dysplasia), 17 cases with resected lung cancer and 31 smokers with symptoms. The respective results of conventional bronchoscopy and LIFE for detection of dysplasia were; sensitivity 52% and 90% (biopsy basis), 62% and 92% (patient basis). Fluorescence bronchoscopy may be an important adjunct to conventional bronchoscopy to improve the localization of subtle lesions of bronchus.
INTRODUCTION
The increasing numbers of lung cancer deaths are mainly due to the detection of the disease at a late stage. Prevention and early detection are essential to decrease the death rate. When roentgenologically occult lung cancer is detected by sputum cytology, the only tool to localize the lesion is endoscopy. However carcinoma in situ can be difficult to identify by conventional white light bronchoscopy alone [1] . Also, the endoscopic apperance of dysplasia is so subtle that even experienced bronchoscopists sometimes fail to localize the lesions. To solve this problem, fluorescence diagnosis was applied to endoscopic imaging by Profio [2] . Kato et al. began a clinical trial using fluorescence bronchoscopy, employing a tumor-specific photosensitizer as a sensitive and accurate method to detect central type early lung cancer in 1980 [3] [4] [5] . Another approach has been made by Palcic and Lam who noticed the difference of autofluorescence between normal and tumor tissue. Using a high quality CCD and special algorithm, they developed the LIFE system [6, 7] . As previously reported [8, 9] , this diagnostic procedure is helpful to detect subtle lesions in the bronchus which can hardly be detected by conventional bronchoscopy.
In this study, the authors will determine if fluorescence bronchoscopy using the LIFE system could improve the diagnostic rate of bronchiallesions, especially early cancer and dysplastic lesions, compared with conventional bronchoscopy.
MATERIALS AND METHODS
A total of 158 subjects were studied from June 1997 to May 1998 in Tokyo Medical University Hospital and 262 sites were biopsied. The criteria for enrollment in this study were as follows:
( (Table V) .
Patient-based Analysis
Of the 158 patients, 68 invasive cancer patients were enrolled in this study as a part of routine examination before treatment (Table IV) [1] . Dysplasia has been regarded as a We postulated that the phenomenon of a high frequency of dysplasia in cancer cases is related to field cancerization, therefore cases with dysplasia should be periodically followed up as high risk cases. Auerbach and co-workers reported in their autopsy study that CIS was found in 15% of the subjects. Also they reported CIS was found in 4.4-11.4% in smokers [14] . [15] . The fluorescence image may reflect some molecular events which are not observed microscopically.
Fluorescence studies are spreading throughout the world, but some problems remain. It is known that there will be some disagreement concerning the diagnosis among pathologists particularly when the specimen is very small. Since it is impossible to distinguish carcinoma in situ from dysplasia using the LIFE system, the histopathology of biopsies is the gold standard. To evaluate the effectiveness of fluorescence studies, more detailed and objective criteria of histopathology of different degrees of dysplasia and carcinoma in situ should be established.
Due to increasing numbers in early cancers as well as more elderly patients, minimally invasive treatment is required to maintain quality of life. As previously reported, surgery can be avoided in some of the in situ and early cancer when treated by photodynamic therapy [16, 17] while chemoprevention might reverse dysplasia to normal status [18] .
At present it has been confirmed that fluorescence examination can be effective to increase the rate of detection of early lesions which can be treated by endoscopic treatment.
